Instil Bio, Inc.TILNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR+98.1%
5Y CAGR+11.6%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+98.1%/yr
Quarterly compound
5Y CAGR
+11.6%/yr
Recent acceleration
Percentile
P82
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 36.49% |
| Q2 2025 | 24.13% |
| Q1 2025 | -137.07% |
| Q4 2024 | 48.33% |
| Q3 2024 | -54.33% |
| Q2 2024 | 38.62% |
| Q1 2024 | -88.02% |
| Q4 2023 | 80.83% |
| Q3 2023 | -261.33% |
| Q2 2023 | 67.30% |
| Q1 2023 | -5.99% |
| Q4 2022 | 4.23% |
| Q3 2022 | 4.69% |
| Q2 2022 | -9.01% |
| Q1 2022 | 2.23% |
| Q4 2021 | -28.71% |
| Q3 2021 | -21.79% |
| Q2 2021 | -52.68% |
| Q1 2021 | -34.58% |
| Q4 2020 | -136.64% |
| Q3 2020 | 21.08% |
| Q2 2020 | -125.04% |
| Q1 2020 | 0.00% |